THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
Dulce is a medicinal cannabis flower with high levels of THC.
It is an indica dominant hybrid and each gram of dried flower contains 24% (w/w) THC and <1% (w/w) CBD.
Kind Dulce™ is a THC-dominant medicinal cannabis flower with high concentrations of THC (delta-9-tetrahydrocannabinol) and low levels of CBD (cannabidiol). All medicinal cannabis products that contain THC are psychoactive and may lead to temporary impairment.
Dulce is available as a dried medicinal cannabis flower and is designed for inhalation using a TGA-approved vaporiser. It can be taken on a metered dosage schedule or as needed (PRN) as determined by prescribers. We recommend patients work closely with their doctor as dosing schedules are highly individual.
10g Dried Flower
Schedule 8 / Category 5
Kind Product Spectrum
Warning: Patients are advised not to drive or operate complex machinery within 24 hours after consuming medication containing THC.
Storage: Store away from direct sunlight in a cool, dry place. Place in a secure location out of the reach of children. Pouches are resealable to preserve shelf-life. Please refer to the back of the packaging for detailed opening and resealing instructions.
The TGA has approved SAS applications including, but not limited to, the following:
Note: The TGA does not endorse medicinal cannabis as a treatment for any condition and does not vouch for the safety or efficacy of medicinal cannabis treatments. It is entirely for the prescribing doctor to determine whether unregistered medicinal cannabis treatments are appropriate for their patient.
Titration is the process of gradually increasing a dose until the desired result is achieved. In line with TGA guidance, we recommend following the “start low, go slow” approach whereby patients start with a low dose and slowly increase until the optimal therapeutic benefit is achieved.
Dosing is highly individual, so patients and doctors should work together to determine the optimal dosing schedule where the medical benefit is maximised within the individual patient’s context.
However, below is an example of a titration schedule:
Accurate dosing and titration of medicinal cannabis flower can be challenging due to several factors. These include inconsistency in the amount of medicine administered, variance in cannabinoid profiles, discrepancies in temperature during vaporisation, and length and depth of breath when inhaled.
For granular control over the dosing of medicinal cannabis, we recommend patients aim to replicate consistently the conditions in which they self-administer medicinal cannabis.
When starting the titration process, patients and doctors should maintain a consistent dosing schedule and adjust dose timing if needed. New medicinal cannabis patients should wait up to 30 minutes between their initial dose before their next inhalation.2
This mindset towards granular control of dosing should extend to determining the specific milligram value of active cannabinoids within dried medicinal cannabis flower. It is often difficult to attain precise dosing with dried medicinal cannabis flower.
The use of a vaporiser to inhale medicinal cannabis is one of the most efficient administration methods for patients. Inhalation offers a rapid onset time, typically providing relief in 5 to 10 minutes, with an expected duration of 2 to 4 hours. This is significantly faster than oral and sublingual ingestion which have an onset period of 1 to 3 hours.3
There are several important factors to understand when inhaling medicinal cannabis. Firstly, utilisation of combustion (smoking paraphernalia) is not recommended due to the risk that smoking poses to patients, including potential contribution to chronic obstructive pulmonary disease (COPD).
Patients should instead opt to use a TGA-approved vaporiser to heat the dried medicinal cannabis flower below the point of combustion to create smoke-free vapour.
Patients should also be aware that temperature settings with vaporisers will impact their medicinal cannabis. Within the dried cannabis flower, each cannabinoid, terpenoid and flavonoid contains a different boiling point.
It should be noted that there are three general temperature bands:
There are more common side effects that are associated with taking medicinal cannabis products for the first time or from increasing usual dosing and may be of a mild and transient nature:
If you experience any of the above side effects for a prolonged period of time (i.e. greater than 24 hours) or if severe, immediately stop taking Kind Dulce™ and speak with your doctor, pharmacist or seek immediate medical attention.
This does not serve as a complete list of potential adverse effects. If you experience any unexpected severe adverse effects not listed, stop using the product immediately and contact your doctor or pharmacist.
Like other medicines, Kind Dulce™ may produce unwanted side effects in some people. With all medicinal cannabis products there are potential adverse effects that may affect only some people.
Rare side effects that warrant immediate cessation of Dulce are:
Should you experience any or several of the above side effects, immediately stop taking Kind Dulce™ and speak to your doctor / pharmacist or go to a hospital.